View all Webinars

Schwegman Lundberg & Woessner

Close     Close Mobile Menu

Categories

Recent

Protecting Intellectual Property Assets Abroad? Choose the Right Team
Sometimes a US patent is only the start. Schwegman’s lead...
Key Drivers and Drags on Future Innovation in Legal Services
Twenty years ago, the offshoring of back-office legal work was...
Tim Bianchi to Speak on Testing Patents in the PTAB at 2019 Midwest IP Institute
An opportunity to learn more about PTAB proceedings is coming...
How ClaimScape Brings Exceptional Value to Clients
Foundation IP, or FIP, is the earliest web-based Intellectual Property...
Attend VLN’s event to help people in poverty obtain legal services
Skilled legal counsel can make an enormous difference in a...
Digital Transformation and the Future of the IP Law Firm
In a previous article, we discussed how SLW has innovated...

Warren Woessner to Speak at Bio IP & Diagnostics Symposium

Warren Woessner, founding shareholder of Schwegman, will be speaking at the Bio IP & Diagnostics Symposium (Bio IPDx) on September 19, 2017, in Alexandria, VA.

Dr. Woessner will be speaking alongside Dr. Leslie Fischer of Novartis and Hans Sauer of Biotechnology Innovation Organization in a panel-style discussion titled “The Walls Are Closing In – The Bleak Future of Claims Reciting Natural ‘Correlations’ and Products of Nature.”  The three will discuss how recent developments regarding section 101 may once again increase patentability in this technology space.

Warren’s practice focuses on chemical patent law, including biotechnology, pharmaceuticals, vaccines, medical treatments, diagnostics, and biofuels and agricultural chemistry, including related opinion and licensing matters. In addition, he has served as an expert witness and also works in mediation of inventorship disputes and solutions for complex prosecution problems.

This seminar will be held at the Westin Alexandria from 7:30 am – 2:15 pm.

Register Here

 

  Back to All News